Ranibizumab Biosimilar - Anti-VEGF mAb - Research Grade
Source
DrugBank DB01270
Species
Human
Molecular weight
48kDa
Purity
>85%
Buffer
PBS pH7.5
Delivery condition
Blue ice (+4°C)
Delivery Time
3-5 days if in stock; 3-5 weeks if production needed
Storage condition
4°C for short term; -20°C for long term
Brand
ProteoGenix
Aliases /Synonyms
Ranibizumab,Ranibizumab,VEGF,anti-VEGF
Reference
PX-TA1008
Note
For research use only. Not suitable for clinical or therapeutic use.
Isotype
FabG1
Clonality
Monoclonal Antibody
Description of Ranibizumab Biosimilar - Anti-VEGF mAb - Research Grade
General information about Ranibizumab
Ranibizumab is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as bevacizumab. It is an anti-angiogenic that has been approved to treat the “wet” type of age-related macular degeneration (AMD, also ARMD), diabetic retinopathy, and macular edema due to branch retinal vein occlusion or central retinal vein occlusion. This product is for research use only.
Reviews
There are no reviews yet.